{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T16:13:29Z","timestamp":1789661609654,"version":"4.0.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001501","name":"University Grants Commission","doi-asserted-by":"publisher","award":["F.25-1\/2014-15 (BSR)\/No. F.5-63\/2007 (BSR) dated 16 February 2015"],"award-info":[{"award-number":["F.25-1\/2014-15 (BSR)\/No. F.5-63\/2007 (BSR) dated 16 February 2015"]}],"id":[{"id":"10.13039\/501100001501","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1007\/s00210-019-01705-3","type":"journal-article","created":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T08:02:46Z","timestamp":1564646566000},"page":"1617-1628","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["Chrysin ameliorates nonalcoholic fatty liver disease in rats"],"prefix":"10.1007","volume":"392","author":[{"given":"Sarayu A.","family":"Pai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renuka P.","family":"Munshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Falguni H.","family":"Panchal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ila-Shruti","family":"Gaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5861-3975","authenticated-orcid":false,"given":"Archana R.","family":"Juvekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,1]]},"reference":[{"key":"1705_CR1","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S0076-6879(84)05016-3","volume":"105","author":"H Aebi","year":"1984","unstructured":"Aebi H (1984) Catalase in vitro. Methods Enzymol 105:121\u2013126","journal-title":"Methods Enzymol"},{"issue":"1\u20132","key":"1705_CR2","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s11010-013-1830-4","volume":"385","author":"N Ali","year":"2014","unstructured":"Ali N, Rashid S, Nafees S, Hasan SK, Sultana S (2014) Beneficial effects of chrysin against methotrexate-induced hepatotoxicity via attenuation of oxidative stress and apoptosis. Mol Cell Biochem 385(1\u20132):215\u2013223. https:\/\/doi.org\/10.1007\/s11010-013-1830-4","journal-title":"Mol Cell Biochem"},{"issue":"10","key":"1705_CR3","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1177\/0748233711399324","volume":"27","author":"KV Anand","year":"2011","unstructured":"Anand KV, Anandhi R, Pakkiyaraj M, Geraldine P (2011) Protective effect of chrysin on carbon tetrachloride (CCl4)-induced tissue injury in male Wistar rats. Toxicol Ind Health 27(10):923\u2013933. https:\/\/doi.org\/10.1177\/0748233711399324","journal-title":"Toxicol Ind Health"},{"issue":"4","key":"1705_CR4","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1111\/j.1447-0594.2012.00843.x","volume":"12","author":"KV Anand","year":"2012","unstructured":"Anand KV, Mohamed Jaabir MS, Thomas PA, Geraldine P (2012) Protective role of chrysin against oxidative stress in d-galactose-induced aging in an experimental rat model. Geriatr Gerontol Int 12(4):741\u2013750. https:\/\/doi.org\/10.1111\/j.1447-0594.2012.00843.x","journal-title":"Geriatr Gerontol Int"},{"issue":"4","key":"1705_CR5","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s00210-015-1207-1","volume":"389","author":"AS Awad","year":"2016","unstructured":"Awad AS, Abd Al Haleem EN, El-Bakly WM, Sherief MA (2016) Thymoquinone alleviates nonalcoholic fatty liver disease in rats via suppression of oxidative stress, inflammation, apoptosis. Naunyn Schmiedeberg's Arch Pharmacol 389(4):381\u2013391. https:\/\/doi.org\/10.1007\/s00210-015-1207-1","journal-title":"Naunyn Schmiedeberg's Arch Pharmacol"},{"issue":"8","key":"1705_CR6","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","volume":"65","author":"E Buzzetti","year":"2016","unstructured":"Buzzetti E, Pinzani M, Tsochatzis EA (2016) The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD). Metabolism 65(8):1038\u20131048. https:\/\/doi.org\/10.1016\/j.metabol.2015.12.012","journal-title":"Metabolism"},{"issue":"9","key":"1705_CR7","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1016\/j.nut.2016.02.007","volume":"32","author":"JH Choi","year":"2016","unstructured":"Choi JH, Yun JW (2016) Chrysin induces brown fat-like phenotype and enhances lipid metabolism in 3T3-L1 adipocytes. Nutrition 32(9):1002\u20131010. https:\/\/doi.org\/10.1016\/j.nut.2016.02.007","journal-title":"Nutrition"},{"issue":"3","key":"1705_CR8","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1002\/tox.20707","volume":"28","author":"O Ciftci","year":"2013","unstructured":"Ciftci O, Vardi N, Ozdemir I (2013) Effects of quercetin and chrysin on 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin induced hepatotoxicity in rats. Environ Toxicol 28(3):146\u2013154. https:\/\/doi.org\/10.1002\/tox.20707","journal-title":"Environ Toxicol"},{"issue":"1","key":"1705_CR9","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1111\/bcp.12899","volume":"83","author":"M Del Ben","year":"2017","unstructured":"Del Ben M, Polimeni L, Baratta F, Pastori D, Angelico F (2017) The role of nutraceuticals for the treatment of non-alcoholic fatty liver disease. Br J Clin Pharmacol 83(1):88\u201395. https:\/\/doi.org\/10.1111\/bcp.12899","journal-title":"Br J Clin Pharmacol"},{"issue":"21","key":"1705_CR10","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1056\/NEJMra1503519","volume":"377","author":"AM Diehl","year":"2017","unstructured":"Diehl AM, Day C (2017) Cause, pathogenesis, and treatment of nonalcoholic steatohepatitis. N Engl J Med 377(21):2063\u20132072. https:\/\/doi.org\/10.1056\/NEJMra1503519","journal-title":"N Engl J Med"},{"issue":"11","key":"1705_CR11","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1002\/ptr.4917","volume":"27","author":"HM El-Bassossy","year":"2013","unstructured":"El-Bassossy HM, Abo-Warda SM, Fahmy A (2013) Chrysin and luteolin attenuate diabetes-induced impairment in endothelial-dependent relaxation: effect on lipid profile, AGEs and NO generation. Phytother Res 27(11):1678\u20131684. https:\/\/doi.org\/10.1002\/ptr.4917","journal-title":"Phytother Res"},{"issue":"11","key":"1705_CR12","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.21960","volume":"31","author":"E Eldutar","year":"2017","unstructured":"Eldutar E, Kandemir FM, Kucukler S, Caglayan C (2017) Restorative effects of chrysin pretreatment on oxidant\u2013antioxidant status, inflammatory cytokine production, and apoptotic and autophagic markers in acute paracetamol-induced hepatotoxicity in rats: an experimental and biochemical study. J Biochem Mol Toxicol 31(11):e21960. https:\/\/doi.org\/10.1002\/jbt.21960","journal-title":"J Biochem Mol Toxicol"},{"issue":"2","key":"1705_CR13","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/0009-8981(73)90016-8","volume":"46","author":"K Falholt","year":"1973","unstructured":"Falholt K, Lund B, Falholt W (1973) An easy colorimetric micromethod for routine determination of free fatty acids in plasma. Clin Chim Acta 46(2):105\u2013111","journal-title":"Clin Chim Acta"},{"key":"1705_CR14","doi-asserted-by":"publisher","unstructured":"Feng X, Qin H, Shi Q, Zhang Y, Zhou F, Wu H, Ding S, Niu Z, Lu Y, Shen P (2014) Chrysin attenuates inflammation by regulating M1\/M2 status via activating PPAR\u03b3. Biochem Pharmacol 89(4):503\u2013514. https:\/\/doi.org\/10.1016\/j.bcp.2014.03.016","DOI":"10.1016\/j.bcp.2014.03.016"},{"issue":"6","key":"1705_CR15","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","volume":"18","author":"WT Friedewald","year":"1972","unstructured":"Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18(6):499\u2013502","journal-title":"Clin Chem"},{"issue":"3","key":"1705_CR16","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1002\/hep.23789","volume":"52","author":"N Ghouri","year":"2010","unstructured":"Ghouri N, Preiss D, Sattar N (2010) Liver enzymes, nonalcoholic fatty liver disease, and incident cardiovascular disease: a narrative review and clinical perspective of prospective data. Hepatology 52(3):1156\u20131161. https:\/\/doi.org\/10.1002\/hep.23789","journal-title":"Hepatology"},{"issue":"8\u20139","key":"1705_CR17","doi-asserted-by":"publisher","first-page":"2030","DOI":"10.1016\/j.fct.2010.04.048","volume":"48","author":"AG Jagtap","year":"2010","unstructured":"Jagtap AG, Patil PB (2010) Antihyperglycemic activity and inhibition of advanced glycation end product formation by Cuminum cyminum in streptozotocin induced diabetic rats. Food Chem Toxicol 48(8\u20139):2030\u20132036. https:\/\/doi.org\/10.1016\/j.fct.2010.04.048","journal-title":"Food Chem Toxicol"},{"issue":"1","key":"1705_CR18","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s00210-018-1567-4","volume":"392","author":"L Jin","year":"2019","unstructured":"Jin L, Fu X, Yao S, Yang J, Ning G, Zhang Z (2019) Protective effects of protopanaxatriol on acute liver injury induced by concanavalin a. Naunyn Schmiedeberg's Arch Pharmacol 392(1):81\u201387. https:\/\/doi.org\/10.1007\/s00210-018-1567-4","journal-title":"Naunyn Schmiedeberg's Arch Pharmacol"},{"issue":"6","key":"1705_CR19","doi-asserted-by":"publisher","first-page":"11963","DOI":"10.3390\/ijms140611963","volume":"14","author":"G Kanuri","year":"2013","unstructured":"Kanuri G, Bergheim I (2013) In vitro and in vivo models of non-alcoholic fatty liver disease (NAFLD). Int J Mol Sci 14(6):11963\u201311980. https:\/\/doi.org\/10.3390\/ijms140611963","journal-title":"Int J Mol Sci"},{"key":"1705_CR20","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.biochi.2016.12.019","volume":"136","author":"S Kersten","year":"2017","unstructured":"Kersten S, Stienstra R (2017) The role and regulation of the peroxisome proliferator activated receptor alpha in human liver. Biochimie 136:75\u201384. https:\/\/doi.org\/10.1016\/j.biochi.2016.12.019","journal-title":"Biochimie"},{"issue":"1","key":"1705_CR21","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.taap.2010.12.004","volume":"251","author":"MS Khan","year":"2011","unstructured":"Khan MS, Devaraj H, Devaraj N (2011) Chrysin abrogates early hepatocarcinogenesis and induces apoptosis in N-nitrosodiethylamine-induced preneoplastic nodules in rats. Toxicol Appl Pharmacol 251(1):85\u201394. https:\/\/doi.org\/10.1016\/j.taap.2010.12.004","journal-title":"Toxicol Appl Pharmacol"},{"key":"1705_CR22","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/j.biopha.2017.04.062","volume":"90","author":"K Kismet","year":"2017","unstructured":"Kismet K, Ozcan C, Kuru S, Gencay Celemli O, Celepli P, Senes M, Guclu T, Sorkun K, Hucumenoglu S, Besler T (2017) Does propolis have any effect on non-alcoholic fatty liver disease? Biomed Pharmacother 90:863\u2013871. https:\/\/doi.org\/10.1016\/j.biopha.2017.04.062","journal-title":"Biomed Pharmacother"},{"issue":"7","key":"1705_CR23","doi-asserted-by":"publisher","first-page":"882","DOI":"10.3390\/nu10070882","volume":"10","author":"EJ Lee","year":"2018","unstructured":"Lee EJ, Kang MK, Kim D, Kim YH, Oh H, Kang YH (2018) Chrysin inhibits advanced glycation end products-induced kidney fibrosis in renal mesangial cells and diabetic kidneys. Nutrients 10(7):882. https:\/\/doi.org\/10.3390\/nu10070882","journal-title":"Nutrients"},{"key":"1705_CR24","doi-asserted-by":"publisher","unstructured":"Lee EJ, Kang MK, Kim YH et al (2019) Dietary chrysin suppresses formation of actin cytoskeleton and focal adhesion in AGE-exposed mesangial cells and diabetic kidney: role of autophagy. Nutrients 11(1):\u2013E127. https:\/\/doi.org\/10.3390\/nu11010127","DOI":"10.3390\/nu11010127"},{"key":"1705_CR25","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","volume":"193","author":"OH Lowry","year":"1951","unstructured":"Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265\u2013275","journal-title":"J Biol Chem"},{"key":"1705_CR26","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.phytochem.2017.09.016","volume":"145","author":"R Mani","year":"2018","unstructured":"Mani R, Natesan V (2018) Chrysin: sources, beneficial pharmacological activities, and molecular mechanism of action. Phytochemistry 145:187\u2013196. https:\/\/doi.org\/10.1016\/j.phytochem.2017.09.016","journal-title":"Phytochemistry"},{"issue":"3","key":"1705_CR27","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1111\/j.1432-1033.1974.tb03714.x","volume":"47","author":"S Marklund","year":"1974","unstructured":"Marklund S, Marklund G (1974) Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem 47(3):469\u2013474","journal-title":"Eur J Biochem"},{"issue":"3","key":"1705_CR28","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s00210-008-0363-y","volume":"379","author":"P Matafome","year":"2009","unstructured":"Matafome P, Nunes E, Louro T, Amaral C, Cris\u00f3stomo J, Rodrigues L, Moedas AR, Monteiro P, Cipriano A, Sei\u00e7a R (2009) A role for atorvastatin and insulin combination in protecting from liver injury in a model of type 2 diabetes with hyperlipidemia. Naunyn Schmiedeberg's Arch Pharmacol 379(3):241\u2013251. https:\/\/doi.org\/10.1007\/s00210-008-0363-y","journal-title":"Naunyn Schmiedeberg's Arch Pharmacol"},{"key":"1705_CR29","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.jnutbio.2018.10.001","volume":"65","author":"M Mazidi","year":"2018","unstructured":"Mazidi M, Katsiki N, Banach M (2018) A higher flavonoid intake is associated with less likelihood of nonalcoholic fatty liver disease: results from a multiethnic study. J Nutr Biochem 65:66\u201371. https:\/\/doi.org\/10.1016\/j.jnutbio.2018.10.001","journal-title":"J Nutr Biochem"},{"issue":"2","key":"1705_CR30","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/0003-2697(79)90738-3","volume":"95","author":"H Ohkawa","year":"1979","unstructured":"Ohkawa H, Ohishi N, Yagi K (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95(2):351\u2013358","journal-title":"Anal Biochem"},{"key":"1705_CR31","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/j.biopha.2018.12","volume":"111","author":"SA Pai","year":"2019","unstructured":"Pai SA, Munshi RP, Panchal FP et al (2019) Plumbagin reduces obesity and nonalcoholic fatty liver disease induced by fructose in rats through regulation of lipid metabolism, inflammation and oxidative stress. Biomed Pharmacother 111:686\u2013694. https:\/\/doi.org\/10.1016\/j.biopha.2018.12","journal-title":"Biomed Pharmacother"},{"issue":"6","key":"1705_CR32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0179654","volume":"12","author":"ENGD Pereira","year":"2017","unstructured":"Pereira ENGD, Silvares RR, Flores EEI et al (2017) Hepatic microvascular dysfunction and increased advanced glycation end products are components of non-alcoholic fatty liver disease. PLoS One 12(6):e0179654. https:\/\/doi.org\/10.1371\/journal.pone.0179654","journal-title":"PLoS One"},{"issue":"1\u20133","key":"1705_CR33","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.ejphar.2009.12.031","volume":"631","author":"G Pushpavalli","year":"2010","unstructured":"Pushpavalli G, Kalaiarasi P, Veeramani C, Pugalendi KV (2010) Effect of chrysin on hepatoprotective and antioxidant status in D-galactosamine-induced hepatitis in rats. Eur J Pharmacol 631(1\u20133):36\u201341. https:\/\/doi.org\/10.1016\/j.ejphar.2009.12.031","journal-title":"Eur J Pharmacol"},{"issue":"5","key":"1705_CR34","doi-asserted-by":"publisher","first-page":"337","DOI":"10.3109\/15376516.2012.759306","volume":"23","author":"S Rashid","year":"2013","unstructured":"Rashid S, Ali N, Nafees S, Ahmad ST, Arjumand W, Hasan SK, Sultana S (2013) Alleviation of doxorubicin-induced nephrotoxicity and hepatotoxicity by chrysin in Wistar rats. Toxicol Mech Methods 23(5):337\u2013345. https:\/\/doi.org\/10.3109\/15376516.2012.759306","journal-title":"Toxicol Mech Methods"},{"issue":"6","key":"1705_CR35","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1016\/j.pharep.2014.06.004","volume":"66","author":"MU Rehman","year":"2014","unstructured":"Rehman MU, Ali N, Rashid S, Jain T, Nafees S, Tahir M, Khan AQ, Lateef A, Khan R, Hamiza OO, Kazim S, Qamar W, Sultana S (2014) Alleviation of hepatic injury by chrysin in cisplatin administered rats: probable role of oxidative and inflammatory markers. Pharmacol Rep 66(6):1050\u20131059. https:\/\/doi.org\/10.1016\/j.pharep.2014.06.004","journal-title":"Pharmacol Rep"},{"key":"1705_CR36","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.biopha.2016.05.013","volume":"82","author":"M Renuka","year":"2016","unstructured":"Renuka M, Vijayakumar N, Ramakrishnan A (2016) Chrysin, a flavonoid attenuates histological changes of hyperammonemic rats: a dose dependent study. Biomed Pharmacother 82:345\u2013354. https:\/\/doi.org\/10.1016\/j.biopha.2016.05.013","journal-title":"Biomed Pharmacother"},{"key":"1705_CR37","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/S0076-6879(94)33041-7","volume":"233","author":"AZ Reznick","year":"1994","unstructured":"Reznick AZ, Packer L (1994) Oxidative damage to proteins: spectrophotometric method for carbonyl. Methods Enzymol 233:357\u2013363","journal-title":"Methods Enzymol"},{"issue":"1","key":"1705_CR38","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1136\/gutjnl-2016-312431","volume":"66","author":"Y Rotman","year":"2017","unstructured":"Rotman Y, Sanyal AJ (2017) Current and upcoming pharmacotherapy for non-alcoholic fatty liver disease. Gut 66(1):180\u2013190. https:\/\/doi.org\/10.1136\/gutjnl-2016-312431","journal-title":"Gut"},{"issue":"4","key":"1705_CR39","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1139\/cjpp-2014-0412","volume":"94","author":"S Samarghandian","year":"2016","unstructured":"Samarghandian S, Azimi-Nezhad M, Samini F, Farkhondeh T (2016) Chrysin treatment improves diabetes and its complications in liver, brain, and pancreas in streptozotocin-induced diabetic rats. Can J Physiol Pharmacol 94(4):388\u2013393. https:\/\/doi.org\/10.1139\/cjpp-2014-0412","journal-title":"Can J Physiol Pharmacol"},{"issue":"4","key":"1705_CR40","doi-asserted-by":"publisher","first-page":"248","DOI":"10.4103\/0975-9476.157951","volume":"6","author":"K Satyanarayana","year":"2015","unstructured":"Satyanarayana K, Sravanthi K, Shaker IA, Ponnulakshmi R, Selvaraj J (2015) Role of chrysin on expression of insulin signaling molecules. J Ayurveda Integr Med 6(4):248\u2013258. https:\/\/doi.org\/10.4103\/0975-9476.157951","journal-title":"J Ayurveda Integr Med"},{"issue":"1","key":"1705_CR41","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/0003-2697(68)90092-4","volume":"25","author":"J Sedlak","year":"1968","unstructured":"Sedlak J, Lindsay RH (1968) Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman\u2019s reagent. Anal Biochem 25(1):192\u2013205","journal-title":"Anal Biochem"},{"issue":"6","key":"1705_CR42","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.tips.2015.04.010","volume":"36","author":"SM Soyal","year":"2015","unstructured":"Soyal SM, Nofziger C, Dossena S, Paulmichl M, Patsch W (2015) Targeting SREBPs for treatment of the metabolic syndrome. Trends Pharmacol Sci 36(6):406\u2013416. https:\/\/doi.org\/10.1016\/j.tips.2015.04.010","journal-title":"Trends Pharmacol Sci"},{"issue":"3","key":"1705_CR43","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1007\/s00535-017-1415-1","volume":"53","author":"Y Sumida","year":"2018","unstructured":"Sumida Y, Yoneda M (2018) Current and future pharmacological therapies for NAFLD\/NASH. J Gastroenterol 53(3):362\u2013376. https:\/\/doi.org\/10.1007\/s00535-017-1415-1","journal-title":"J Gastroenterol"},{"issue":"4","key":"1705_CR44","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1093\/alcalc\/agr038","volume":"46","author":"M Tahir","year":"2011","unstructured":"Tahir M, Sultana S (2011) Chrysin modulates ethanol metabolism in Wistar rats: a promising role against organ toxicities. Alcohol Alcohol 46(4):383\u2013392. https:\/\/doi.org\/10.1093\/alcalc\/agr038","journal-title":"Alcohol Alcohol"},{"issue":"Suppl 1","key":"1705_CR45","doi-asserted-by":"publisher","first-page":"jeb164202","DOI":"10.1242\/jeb.164202","volume":"221","author":"L Tappy","year":"2018","unstructured":"Tappy L (2018) Fructose-containing caloric sweeteners as a cause of obesity and metabolic disorders. J Exp Biol 221(Suppl 1):jeb164202. https:\/\/doi.org\/10.1242\/jeb.164202","journal-title":"J Exp Biol"},{"issue":"7","key":"1705_CR46","doi-asserted-by":"publisher","first-page":"e180","DOI":"10.1111\/liv.12523","volume":"34","author":"Z Tariq","year":"2014","unstructured":"Tariq Z, Green CJ, Hodson L (2014) Are oxidative stress mechanisms the common denominator in the progression from hepatic steatosis towards non-alcoholic steatohepatitis (NASH)? Liver Int 34(7):e180\u2013e190. https:\/\/doi.org\/10.1111\/liv.12523","journal-title":"Liver Int"},{"key":"1705_CR47","doi-asserted-by":"publisher","unstructured":"Taslimi P, Kandemir FM, Demir Y, \u0130lerit\u00fcrk M, Temel Y, Caglayan C, Gul\u00e7in \u0130 (2019) The antidiabetic and anticholinergic effects of chrysin on cyclophosphamide-induced multiple organ toxicity in rats: pharmacological evaluation of some metabolic enzyme activities. J Biochem Mol Toxicol doi. https:\/\/doi.org\/10.1002\/jbt.22313","DOI":"10.1002\/jbt.22313"},{"key":"1705_CR48","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1016\/j.biopha.2017.11.072","volume":"96","author":"C Veeramani","year":"2017","unstructured":"Veeramani C, Alsaif MA, Al-Numair KS (2017) Lavatera critica, a green leafy vegetable, controls high fat diet induced hepatic lipid accumulation and oxidative stress through the regulation of lipogenesis and lipolysis genes. Biomed Pharmacother 96:1349\u20131357. https:\/\/doi.org\/10.1016\/j.biopha.2017.11.072","journal-title":"Biomed Pharmacother"},{"issue":"6","key":"1705_CR49","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.2337\/diacare.27.6.1487","volume":"27","author":"TM Wallace","year":"2004","unstructured":"Wallace TM, Levy JC, Matthews DR (2004) Use and abuse of HOMA modeling. Diabetes Care 27(6):1487\u20131495","journal-title":"Diabetes Care"},{"issue":"6","key":"1705_CR50","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1002\/hep.30251","volume":"69","author":"Z Younossi","year":"2019","unstructured":"Younossi Z, Tacke F, Arrese M, Chander Sharma B, Mostafa I, Bugianesi E, Wai-Sun Wong V, Yilmaz Y, George J, Fan J, Vos MB (2019) Global perspectives on non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. Hepatology 69(6):2672\u20132682. https:\/\/doi.org\/10.1002\/hep.30251","journal-title":"Hepatology"},{"issue":"6","key":"1705_CR51","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1007\/s00210-015-1102-9","volume":"388","author":"SA Zaitone","year":"2015","unstructured":"Zaitone SA, Barakat BM, Bilasy SE, Fawzy MS, Abdelaziz EZ, Farag NE (2015) Protective effect of boswellic acids versus pioglitazone in a rat model of diet-induced non-alcoholic fatty liver disease: influence on insulin resistance and energy expenditure. Naunyn Schmiedeberg's Arch Pharmacol 388(6):587\u2013600. https:\/\/doi.org\/10.1007\/s00210-015-1102-9","journal-title":"Naunyn Schmiedeberg's Arch Pharmacol"},{"key":"1705_CR52","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.toxrep.2014.02.003","volume":"1","author":"MS Zarzecki","year":"2014","unstructured":"Zarzecki MS, Araujo SM, Bortolotto VC, de Paula MT, Jesse CR, Prigol M (2014) Hypolipidemic action of chrysin on triton WR-1339-induced hyperlipidemia in female C57BL\/6 mice. Toxicol Rep 1:200\u2013208. https:\/\/doi.org\/10.1016\/j.toxrep.2014.02.003","journal-title":"Toxicol Rep"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-019-01705-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00210-019-01705-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-019-01705-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,15]],"date-time":"2021-01-15T19:00:14Z","timestamp":1610737214000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00210-019-01705-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,1]]},"references-count":52,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1705"],"URL":"https:\/\/doi.org\/10.1007\/s00210-019-01705-3","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,1]]},"assertion":[{"value":"12 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All experimental protocols described in this paper were approved by the Institutional Animal Ethics Committee of T. N. Medical College and BYL Nair Charitable Hospital (protocol no. TNMC\/IAEC\/2016\/8B). All institutional and national guidelines for the care and use of laboratory animals were followed.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statement on the welfare of animals"}}]}}